Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023

BUY
$233.08 - $265.59 $233 - $265
1 Added 2.7%
38 $9,000
Q2 2023

Aug 15, 2023

BUY
$224.99 - $256.14 $4,049 - $4,610
18 Added 94.74%
37 $9,000
Q1 2023

May 18, 2023

BUY
$239.75 - $277.0 $4,555 - $5,263
19 New
19 $5,000
Q1 2022

May 17, 2022

SELL
$257.27 - $315.76 $84,641 - $103,885
-329 Closed
0 $0
Q4 2021

Feb 18, 2022

BUY
$292.08 - $329.01 $96,094 - $108,244
329 New
329 $2,000
Q3 2021

Nov 16, 2021

SELL
$272.21 - $332.43 $20,687 - $25,264
-76 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$212.38 - $245.9 $4,247 - $4,918
20 Added 35.71%
76 $17,000
Q4 2020

Mar 02, 2021

BUY
$212.5 - $245.46 $11,900 - $13,745
56 New
56 $12,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $173B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Sky View Investment Advisors, LLC Portfolio

Follow Sky View Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky View Investment Advisors, LLC with notifications on news.